STAAR Surgical Company
STAA
$29.29
-$1.92-6.15%
NASDAQ
| 04/03/2026 | 01/02/2026 | 09/26/2025 | 06/27/2025 | 03/28/2025 | |
|---|---|---|---|---|---|
| Net Income | 128.43% | -306.09% | 152.84% | 68.99% | -58.38% |
| Total Depreciation and Amortization | 4.98% | 0.35% | 1.27% | -15.49% | -1.60% |
| Total Amortization of Deferred Charges | -74.57% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.80% | -51.02% | 553.26% | -80.55% | 125.19% |
| Change in Net Operating Assets | -4,719.91% | 103.00% | -94.03% | -156.02% | 15.10% |
| Cash from Operations | -454.29% | -246.76% | 109.79% | -375.22% | -993.15% |
| Capital Expenditure | 73.58% | -89.92% | 50.73% | -22.07% | 74.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 114.60% | -387.67% | -77.09% | -26.91% | 367.39% |
| Cash from Investing | 111.06% | -467.50% | -78.97% | -28.94% | 281.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | -2.44% |
| Issuance of Common Stock | 52.63% | -96.16% | 24,608.33% | -96.82% | 842.50% |
| Repurchase of Common Stock | -1,038.41% | 91.73% | 56.46% | -254.79% | -1,077.06% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3,286.00% | -105.09% | 121.65% | -378.90% | -761.82% |
| Foreign Exchange rate Adjustments | -112.03% | 310.99% | -86.73% | 139.86% | 132.46% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.47% | -354.93% | 250.83% | -120.66% | 245.91% |